Medical News

RSS

Vital molecular mechanism in plants has similarities to certain signaling mechanisms in humans

Scientists at Van Andel Research Institute have revealed an important molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer.

25 Jul 2015

Girls are born with weaker spines compared to boys, study finds

Looking at measurements of the vertebrae - the series of small bones that make up the spinal column - in newborn children, investigators at Children's Hospital Los Angeles found that differences between the sexes are present at birth. Results of the study, now online in advance of publication in the August issue of the Journal of Pediatrics, suggest that this difference is evolutionary, allowing the female spine to adapt to the fetal load during pregnancy.

25 Jul 2015

New research shows concussion may affect men and women differently

New research suggests concussion may not significantly impair symptoms or cognitive skills for one gender over another, however, women may still experience greater symptoms and poorer cognitive performance at preseason testing.

25 Jul 2015

Higher case volume linked with improved outcomes for catheter-based blood clot removal in LE-DVT patients

Patients who have lower extremity proximal deep vein thrombosis (LE-DVT), or a blood clot in their leg, are increasingly undergoing minimally invasive catheter-based blood clot removal - also referred to as catheter-directed thrombolysis (CDT) - rather than solely being treated with traditional blood-thinning medications (anticoagulation alone).

25 Jul 2015

New paper describes positive effects of CRAC channel inhibitors in animal models of acute pancreatitis

Researchers from CalciMedica, Inc. and the University of Liverpool today announced the publication of a paper describing positive effects of calcium release-activated calcium (CRAC) channel inhibitors in animal models of acute pancreatitis. The paper, titled "Inhibitors of ORAI1 prevent cytosolic calcium-associated injury of human pancreatic acinar cells and acute pancreatitis in 3 mouse models" appears in the August edition of the journal Gastroenterology.

25 Jul 2015

Corgenix Medical to present several scientific abstracts at 2015 AACC Clinical Lab Expo

Corgenix Medical Corporation, the U.S. - based operation of ORGENTEC Diagnostika, is presenting several scientific abstracts at the 2015 American Association for Clinical Chemistry Clinical Lab Expo in Atlanta. Three abstracts involve the ReEBOV Ebola rapid diagnostic test (RDT) with a fourth abstract involving the AtherOx™ Assay for assessing heart disease risk.

25 Jul 2015

WWP's Physical Health and Wellness Program hosts wounded veterans for fitness and nutrition seminar

The Wounded Warrior Project Physical Health and Wellness Program hosted a group of wounded veterans for a full-day fitness and nutrition seminar at Revolution Fitness in New Orleans, Louisiana. Revolution Fitness is an elite athletic training facility that combines functional training tools and innovative programs to ensure optimal physical performance.

25 Jul 2015

Study points to new treatment strategies for liver cancer

A new study by researchers at Sanford Burnham Prebys Medical Discovery Institute, the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a key immune receptor, the lymphotoxin-beta receptor (LTβR), reduces the progression of liver cancer.

25 Jul 2015

'Watch' issued to help surgeons reduce potential risks associated with all-inside meniscal repairs

JBJS Case Connector, an online case report journal published by The Journal of Bone and Joint Surgery, has issued a "Watch" regarding potential risks with anchor-based all-inside meniscal repairs. While all-inside techniques have many advantages, including shorter surgical time and reduced risk of damage to neurovascular tissues, potential drawbacks include risks of local soft-tissue irritation and implant migration or breakage.

25 Jul 2015

New book provides overview of treatment options for paediatric calcium and bone disorders

Knowledge about paediatric calcium and bone disorders has increased rapidly over the past twenty years. Great advances have been made in the underlying genetic basis for many conditions, in bone density and geometry imaging and in the development of new treatment options, calling for a new edition of 'Calcium and Bone Disorders in Children and Adolescents' which was first published in 2009.

25 Jul 2015

Researchers decode molecular mechanism of fish toxin that has potential to treat cancer

Pathogenic bacteria develop killer machines that work very specifically and highly efficiently. Scientists from the University of Freiburg have solved the molecular mechanism of a fish toxin that could be used in the future as a medication to treat cancer. The scientists have now published their research in the journal Nature Communications.

25 Jul 2015

Metabolic imbalance caused by radiation from wireless devices linked to many health risks

A metabolic imbalance caused by radiation from your wireless devices could be the link to a number of health risks, such as various neurodegenerative diseases and cancer, a recent study suggests.

25 Jul 2015

Bowel Cancer UK to be part of Genomics England genome sequencing project for bowel cancer

Bowel Cancer UK is pleased to announce that the charity will be part of the lead committee on bowel cancer in the Genomics England genome sequencing project.

25 Jul 2015

CHMP recommends Zalviso for management of acute post-operative pain in adult patients

AcelRx Pharmaceuticals, Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency, has adopted a positive opinion for Zalviso (sufentanil sublingual tablets).

25 Jul 2015

National Psoriasis Foundation introduces patient-centered research network

For the first time, people with psoriasis and psoriatic arthritis can contribute directly to the future of research into these chronic, systemic autoimmune diseases through the National Psoriasis Foundation's patient-centered research network called Citizen Pscientist.

25 Jul 2015

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Novartis today announced the US Food and Drug Administration has approved Odomzo (sonidegib, formerly LDE225) 200 mg capsules for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.

25 Jul 2015

Lupin signs strategic asset purchase agreement with Temmler

Pharma Major Lupin Limited today announced that it has entered into a strategic asset purchase agreement with TEMMLER PHARMA GMBH & CO. KG, a part of the Aenova Group, one of the world's largest pharmaceutical contract manufacturers, to acquire Temmler's specialty product portfolio subject to certain closing conditions.

25 Jul 2015

ALCF to honor Fred R. Hirsch with 2015 Addario Lectureship Award for lung cancer research

The Bonnie J. Addario Lung Cancer Foundation will honor Fred R. Hirsch, M.D., Ph.D., with the 2015 Addario Lectureship Award for his continued leadership and expertise in lung cancer treatment and research. Dr. Hirsch, CEO of the International Association for the Study of Lung Cancer, will receive the award at the 16th International Lung Cancer Congress held on July 30 – August 1 in Huntington Beach, California.

25 Jul 2015

Texas Institute for Surgery receives five-star rating for patient satisfaction

Texas Institute for Surgery at Texas Health Presbyterian Dallas received the maximum grade of five stars in a rating of patients' experience of care of more than 3,500 hospitals that is posted on a federal government website.

25 Jul 2015

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors.

25 Jul 2015

Medical News

Vital molecular mechanism in plants has similarities to certain signaling mechanisms in humans

Girls are born with weaker spines compared to boys, study finds

New research shows concussion may affect men and women differently

Higher case volume linked with improved outcomes for catheter-based blood clot removal in LE-DVT patients

New paper describes positive effects of CRAC channel inhibitors in animal models of acute pancreatitis

Corgenix Medical to present several scientific abstracts at 2015 AACC Clinical Lab Expo

WWP's Physical Health and Wellness Program hosts wounded veterans for fitness and nutrition seminar

Study points to new treatment strategies for liver cancer

'Watch' issued to help surgeons reduce potential risks associated with all-inside meniscal repairs

New book provides overview of treatment options for paediatric calcium and bone disorders

Researchers decode molecular mechanism of fish toxin that has potential to treat cancer

Metabolic imbalance caused by radiation from wireless devices linked to many health risks

Bowel Cancer UK to be part of Genomics England genome sequencing project for bowel cancer

CHMP recommends Zalviso for management of acute post-operative pain in adult patients

National Psoriasis Foundation introduces patient-centered research network

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Lupin signs strategic asset purchase agreement with Temmler

ALCF to honor Fred R. Hirsch with 2015 Addario Lectureship Award for lung cancer research

Texas Institute for Surgery receives five-star rating for patient satisfaction

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News